"Strategic investments in external innovation are a key component of our strategy. MS Ventures demonstrates our commitment to create long term relationships with and tap into the innovative entrepreneurial spirit of biotech companies."
Member of the Executive Board of Merck KGaA, Darmstadt, Germany
and Head of the Pharmaceuticals Business of the Merck KGaA
SUSAN JANE HERBERT
"We are proud of our strong track record of establishing fruitful collaborative relations with external partners aiming to develop the next generation of therapies. MS Ventures allows us to establish those relations early on to facilitate broader collaborations as technologies mature."
Susan Jane Herbert
EVP, Head of Global Business Development and Strategy,
Biopharmaceutical division of Merck KGaA, Darmstadt, Germany